February, marked globally as Cancer Prevention Month, is a time to renew our commitment to reducing the impact of cancer. This month serves as a reminder of the significant strides made in cancer research, treatment, and prevention. However, it also underscores the need for continued vigilance and...

Learn about the symptoms, treatments, and management of the most common types of blood cancer. Key takeaways: Blood cancer has three common forms Various medical procedures are available to treat these forms of the disease Early detection can make treatments more effective Over 1.3 million...

Pfizer's acute myeloid leukemia (AML) medicine Mylotarg (gemtuzumab, ozogamicin) has been granted Orphan Drug Designation by the US Food and Drug Administration (FDA). The drug is indicated for the treatment of adults with newly diagnosed AML whose tumors express the CD33 antigen (CD33-positive...

Vyxeos (daunorubicin and cytarabine) has been approved by the US Food and Drug Administration (FDA). It is the first treatment approved for patients with certain types of high-risk acute myeloid leukemia (AML). The drug, developed by Jazz Pharmaceuticals, is a fixed combination of two chemotherapy...